Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives
Circulation: Cardiovascular Interventions · 2023-05 · 16 (5)
DOI: 10.1161/circinterventions.122.012812 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-05. Verfasst von Jules Mesnier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Québec City, Canada (J.M., K.H.T., G.O., J.R.-C.). Hauptthemen laut MEDLINE: Stroke, Atrial Appendage, Atrial Fibrillation, Thrombosis. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Left atrial appendage closure is an alternative to chronic oral anticoagulation to prevent embolic events related to nonvalvular atrial fibrillation. After device implantation, antithrombotic treatment is prescribed to prevent device-related thrombosis, a dreadful complication associated with an increased risk of ischemic events. However, the optimal antithrombotic treatment after left atrial appendage closure, effective on both device-related thrombus prevention and bleeding risk mitigation, remains to be determined. In more than 10 years experience with left atrial appendage closure, a wide range of antithrombotic treatments have been used, mostly in observational studies. In this review, we analyzed the body of evidence for each antithrombotic regimen after left atrial appendage closure to provide tools to guide the physician choice and describe future perspectives in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quebec Heart and Lung Institute, Laval University, Québec City, Canada (J.M., K.H.T., G.O., J.R.-C.).
- Cardiovascular Department, Cardiovascular Institute, Clínic Barcelona, Spain (P.C.-G., X.F., E.F.-U.).
ORCID-Profile: Jules Mesnier, Pedro Cepas-Guillén, Eduardo Flores-Umanzor, Kim Hoang Trinh, Gilles O'Hara, Josep Rodés-Cabau
Zitieren
APA
Mesnier, J., Cepas-Guillén, P., Freixa, X., Flores-Umanzor, E., Hoang Trinh, K., O'Hara, G., & Rodés-Cabau, J. (2023). Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives. Circulation: Cardiovascular Interventions, 16(5). https://doi.org/10.1161/circinterventions.122.012812
Vancouver
Mesnier J, Cepas-Guillén P, Freixa X, Flores-Umanzor E, Hoang Trinh K, O'Hara G, et al. Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives. Circulation: Cardiovascular Interventions. 2023;16(5). doi:10.1161/circinterventions.122.012812
BibTeX
@article{Mesnier2023,
author = {Mesnier, Jules and Cepas-Guillén, Pedro and Freixa, Xavier and Flores-Umanzor, Eduardo and Hoang Trinh, Kim and O'Hara, Gilles and Rodés-Cabau, Josep},
title = {Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives},
journal = {Circulation: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {5},
doi = {10.1161/circinterventions.122.012812}
}
EUVIMED